PSI Immunology is a Platform of Immunological Solutions to develop products and processes to replace or reduce the use of […]
Although it does not seem, Brazil has always had a prominent position in drug development. Several drug development stages pass
Biominas Brasil and Di Blasi, Parente & Advogados Associados law firm were invited by the Industrial Biotechnology Journal to publish
By Laura Lunardi, Technical Analyst of Biominas Brasil and Guilherme Marinho, Entrepreneurship Analyst of Biominas Brasil On Tuesday, 22/03/16, PL4639 (law draft) was
By Laura Lunardi, Technical Analyst of Biominas Brasil Recently, the Department of Science, Technology and Strategic Inputs of the Ministry
Natália Souza | Consultancy & Business Development of Biominas Brasil Mutations in over three thousand of the currently known human genes
By Carolina de Andrade, Technical Analyst of Biominas Brasil An emerging infection is happening in the Americas, an epidemic caused
By Josiely Gomes, Coordinator | Consultancy & Business Development of Biominas Brasil The new regulatory framework for Science, Technology and Innovation (S,T&I)
By Biominas Brasil and Serpa Group We all know that 2015 was a year of economic crisis in Brazil. Political
Brazil is currently going through an economic crisis. How can internationalization help companies in these tough times? Fabrizio Conicella –
